ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 40047902. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $647,000 | +12.1% | 369,500 | +9.5% | 0.01% | 0.0% |
| Q2 2016 | $577,000 | -0.9% | 337,400 | +14.2% | 0.01% | -12.5% |
| Q1 2016 | $582,000 | +59.9% | 295,400 | +54.0% | 0.01% | +100.0% |
| Q4 2015 | $364,000 | -34.5% | 191,800 | -34.1% | 0.00% | -50.0% |
| Q3 2015 | $556,000 | -71.7% | 290,900 | -31.3% | 0.01% | -70.4% |
| Q2 2015 | $1,965,000 | -34.4% | 423,500 | -38.2% | 0.03% | -42.6% |
| Q1 2015 | $2,997,000 | +12.0% | 685,800 | -11.1% | 0.05% | +17.5% |
| Q4 2014 | $2,675,000 | +16.3% | 771,000 | +40.4% | 0.04% | +14.3% |
| Q3 2014 | $2,301,000 | -70.5% | 549,200 | -58.7% | 0.04% | -70.8% |
| Q2 2014 | $7,791,000 | -34.1% | 1,329,600 | -29.1% | 0.12% | -39.7% |
| Q1 2014 | $11,818,000 | +13.6% | 1,875,800 | +5.5% | 0.20% | +26.8% |
| Q4 2013 | $10,401,000 | +99.4% | 1,777,900 | +79.7% | 0.16% | +57.0% |
| Q3 2013 | $5,215,000 | – | 989,600 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,777,900 | $10,401,000 | 0.16% |